Alexander D. Macrae
President & Chief Executive Officer; Director
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Sangamo Therapeutics, Inc (SGMOQ) | Chief Executive Officer | $716,366 | $2,457,450 |
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $716,366 | $2,392,272 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $709,273 | $4,806,435 |
| 2021 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $688,615 | $4,735,817 |
| 2020 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $681,797 | $3,835,030 |
| 2019 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $661,939 | $3,986,555 |
| 2018 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $636,480 | $4,104,428 |
| 2017 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $612,000 | $1,795,856 |
Executive changes
Earnings-call appearances
-
Sangamo Therapeutics, Inc Q2 FY2025 Earnings Call2025-08-07
Sangamo Therapeutics, Inc (SGMOQ)
-
Sangamo Therapeutics, Inc Q1 FY2023 Earnings Call2023-04-26
Sangamo Therapeutics, Inc (SGMOQ)